Assuming regulatory approvals are granted - and there's no indication there is an issue here - this is done. Trading at a gross/annualised spread of 1.8%/9.4%.
What is covered in the Full Insight:
Summary of the Deal
The Scheme Booklet
The Independent Expert opinion
Overview of CSR
Shareholder Register
SUMMARY
(Sign Up to Access)
Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
Unlock all research summaries
Follow top, independent analysts
Receive personalised alerts and emails
Access Briefings, Analytics, and Events
Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.
Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.